Su YX - Search Results

1

Chemotherapy regimens containing taxanes or fluorouracil in nasopharyngeal carcinoma: Which better?

Mi JL, Zhang B, Pan YF, Su YX, Fan JF, Liao SF, Qin XL, Yao DC, Tang HY, Jiang W. Mi JL, et al. Among authors: su yx. Oral Oncol. 2017 Nov;74:34-39. doi: 10.1016/j.oraloncology.2017.09.003. Oral Oncol. 2017. PMID: 29103749

2

Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma : A matched-pair multicenter analysis of outcomes.

Dong YY, Xiang C, Lu JX, Su YX, Pan YF, Cai R, Zhang RJ, He ZK, Liu ML, Huang H, Bai X, Tang HY, Shi YH, Wang Y, Jiang W. Dong YY, et al. Among authors: su yx. Strahlenther Onkol. 2016 Jun;192(6):394-402. doi: 10.1007/s00066-016-0970-3. Epub 2016 May 23. Strahlenther Onkol. 2016. PMID: 27215563 English.

3

Feasibility and efficiency of double-agent versus single-agent concurrent chemoradiotherapy in patients with nasopharyngeal carcinoma.

Qin G, Rai R, Zhang R, Su Y, Zhang B, Pan Y, Xiong R, Xie Y, Yang H, Kong X, Luo Z, Ruan X, Mo Y, Aftab O, Shahisanjeev, Jazib, Jiang W. Qin G, et al. Oral Oncol. 2020 Jul;106:104704. doi: 10.1016/j.oraloncology.2020.104704. Epub 2020 Apr 21. Oral Oncol. 2020. PMID: 32330685

4

Hypofractionated radiotherapy compared with conventionally fractionated radiotherapy to treat initial distant metastases in nasopharyngeal carcinoma: A multicenter, prospective, randomized, phase II trial.

Liu J, Zhang B, Su Y, Qin G, Kong X, Mo Y, Zhang R, Jiang W. Liu J, et al. Radiother Oncol. 2023 Oct;187:109815. doi: 10.1016/j.radonc.2023.109815. Epub 2023 Jul 20. Radiother Oncol. 2023. PMID: 37480994 Clinical Trial.

5

Apatinib combined with camrelizumab in the treatment of recurrent/metastatic nasopharyngeal carcinoma: a prospective multicenter phase II study.

Mo Y, Pan Y, Zhang B, Zhang J, Su Y, Liu Z, Luo M, Qin G, Kong X, Zhang R, Pan Y, Liang Y, Wang D, Wei Y, Chen H, Jiang W. Mo Y, et al. Front Immunol. 2024 Jan 3;14:1298418. doi: 10.3389/fimmu.2023.1298418. eCollection 2023. Front Immunol. 2024. PMID: 38239359 Free PMC article. Clinical Trial.

6

Intensity-modulated radiotherapy alone compared with intensity-modulated radiotherapy plus concurrent chemotherapy in intermediate-risk nasopharyngeal carcinoma : A prospective multicenter phase II trial.

Liao S, Zhang B, Su Y, Pan Y, Zhang J, Ye Z, Zhang R, Kong X, Qin G, Mo Y, Ruan X, Liu J, Gan C, Dai J, Zhang R, Luo G, Liao X, Jiang W. Liao S, et al. Strahlenther Onkol. 2024 Feb 7. doi: 10.1007/s00066-024-02201-1. Online ahead of print. Strahlenther Onkol. 2024. PMID: 38324078

7

Induction Chemotherapy Followed by Radiotherapy vs Chemoradiotherapy in Nasopharyngeal Carcinoma: A Randomized Clinical Trial.

Dai J, Zhang B, Su Y, Pan Y, Ye Z, Cai R, Qin G, Kong X, Mo Y, Zhang R, Liu Z, Xie Y, Ruan X, Jiang W. Dai J, et al. JAMA Oncol. 2024 Apr 1;10(4):456-463. doi: 10.1001/jamaoncol.2023.6552. JAMA Oncol. 2024. PMID: 38329737 Clinical Trial.

8

FOXO1 reshapes neutrophils to aggravate acute brain damage and promote late depression after traumatic brain injury.

Zhou M, Liu YW, He YH, Zhang JY, Guo H, Wang H, Ren JK, Su YX, Yang T, Li JB, He WH, Ma PJ, Mi MT, Dai SS. Zhou M, et al. Among authors: su yx. Mil Med Res. 2024 Mar 31;11(1):20. doi: 10.1186/s40779-024-00523-w. Mil Med Res. 2024. PMID: 38556884 Free PMC article.

9

Long-term stability of jaw reconstruction with microvascular bone flaps: A prospective longitudinal study.

Pu JJ, Choi WS, Wong MCM, Wu S, Leung PH, Yang WF, Su YX. Pu JJ, et al. Among authors: su yx. Oral Oncol. 2024 May;152:106780. doi: 10.1016/j.oraloncology.2024.106780. Epub 2024 Mar 30. Oral Oncol. 2024. PMID: 38555752 Free article.

10

Post-COVID-19 Pandemic Rebound of Macrolide-Resistant Mycoplasma pneumoniae Infection: A Descriptive Study.

Xing FF, Chiu KH, Deng CW, Ye HY, Sun LL, Su YX, Cai HJ, Lo SK, Rong L, Chen JL, Cheng VC, Lung DC, Sridhar S, Chan JF, Hung IF, Yuen KY. Xing FF, et al. Among authors: su yx. Antibiotics (Basel). 2024 Mar 15;13(3):262. doi: 10.3390/antibiotics13030262. Antibiotics (Basel). 2024. PMID: 38534697 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

262 results

Search Page